Agencourt, Ambion Pen Reagent Distribution Deal | GenomeWeb

NEW YORK, Sept. 16 (GenomeWeb News) - Agencourt Bioscience said today that it has signed a distribution agreement with Ambion for its SPRI (Solid-Phase Reversible Immobilization) nucleic acid purification reagent.

Under the terms of the agreement, Ambion will distribute the reagent, called AMPure, as part of its MessageAmp RNA amplification kit.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.